- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05324228
Sublingual Microcirculation in Healthy Children Using the SDF Imaging Method
Determination of Reference Values for Sublingual Microcirculation in Healthy Volunteers in the Pediatric Population Using the Sidestream Dark-Field Imaging Method
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ústí Nad Labem, Czechia
- Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- healthy child
- informed consent of parents
Exclusion Criteria:
- inability to cooperate
- acute illness
- chronic illness
- chronic medication
- substance abuse
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
Preschool children
10 preschool healthy children aged 3-5,9 years.
|
|
Children of younger school age
10 children of younger school age aged 6-10,9 years.
|
|
Children in puberty
10 children in puberty aged 11-14,9 years
|
|
Postpubertal adolescents
10 postpubertal adolescents aged 15-18,9 years.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Determination of Total Vascular Density of sublingual microcirculation of children
Time Frame: baseline
|
Total length of vessels divided by total surface of area
|
baseline
|
|
Determination of Microvascular Flow Index (MFI) of sublingual microcirculation of children
Time Frame: baseline
|
The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant.
The MFI score represents the averaged values of the four.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
|
baseline
|
|
Determination of Small Vessel Density of sublingual microcirculation of children
Time Frame: baseline
|
Total length of small vessels divided by total surface of area.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
|
baseline
|
|
Determination of Proportion of Perfused Vessels (all) of sublingual microcirculation of children
Time Frame: baseline
|
The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels.
|
baseline
|
|
Determination of Proportion of Perfused Small Vessels (PPV) of sublingual microcirculation of children
Time Frame: baseline
|
The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). |
baseline
|
|
Determination of Perfused Vessel Density (all) of sublingual microcirculation of children
Time Frame: baseline
|
Total length of vessels - (no flow + intermittent flow) divided by total surface of area
|
baseline
|
|
Determination of Perfused Small Vessel Density (PVD) of sublingual microcirculation of children
Time Frame: baseline
|
Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
|
baseline
|
|
Determination of DeBacker Score of sublingual microcirculation of children
Time Frame: baseline
|
In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen.
Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines.
|
baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in Total Vascular Density in children of different age categories
Time Frame: baseline
|
Total length of vessels divided by total surface of area.
Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in Microvascular Flow Index (MFI) in children of different age categories
Time Frame: baseline
|
The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant.
The MFI score represents the averaged values of the four.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in Small Vessel Density in children of different age categories
Time Frame: baseline
|
Total length of small vessels divided by total surface of area.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in Proportion of Perfused Vessels (all) in children of different age categories
Time Frame: baseline
|
The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels.
Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in Perfused Vessel Density (all) in children of different age categories
Time Frame: baseline
|
Total length of vessels - (no flow + intermittent flow) divided by total surface of area.
Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in Proportion of Perfused Small Vessels (PPV) in children of different age categories
Time Frame: baseline
|
The proportion of perfused small vessels (PPV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules). Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years. |
baseline
|
|
Differences in Perfused Small Vessel Density (PVD) in children of different age categories
Time Frame: baseline
|
Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area.
A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
|
Differences in DeBacker Score in children of different age categories
Time Frame: baseline
|
In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen.
Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines.
Comparison in children aged 3-5,9; 6-10,9; 11-14,9; and 15-18,9 years.
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: David Neumann, MD, Ph.D, University Hospital in Hradec Kralove
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 300/7
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.